Permethrin and Skin exfoliation - a phase IV clinical study of FDA data

Summary:

Skin exfoliation is reported as a side effect among people who take Permethrin (permethrin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dupixent, and have Acarodermatitis.

The phase IV clinical study analyzes which people have Skin exfoliation when taking Permethrin. It is created by eHealthMe based on reports of 1,521 people who have side effects when taking Permethrin from the FDA, and is updated regularly.

What is Permethrin?

Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.

What is Skin exfoliation?

Skin exfoliation (removal of the oldest dead skin cells) is found to be associated with 1,731 drugs and 1,994 conditions by eHealthMe. Check the latest studies of Skin exfoliation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

1,521 people reported to have side effects when taking Permethrin.
Among them, 15 people (0.99%) have Skin exfoliation.

Could Permethrin cause Skin exfoliation?

Among these 15 people:

How long have people been on Permethrin when they have Skin exfoliation? *

What is the gender of people who have Skin exfoliation when taking Permethrin? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Skin exfoliation when taking Permethrin? *

What are other drugs people take besides Permethrin? *

Dupixent: 4 people, 26.67%
Stelara: 3 people, 20.00%
Cosentyx: 3 people, 20.00%
Vitamin B12: 1 person, 6.67%
Triamcinolone Acetonide: 1 person, 6.67%
Tretinoin: 1 person, 6.67%
Sodium Sulfacetamide: 1 person, 6.67%
Prednisone: 1 person, 6.67%
Hydroxyzine: 1 person, 6.67%
Folic Acid: 1 person, 6.67%

What are other side effects people have besides Skin exfoliation? *

Itching: 8 people, 53.33%
Dry Skin: 7 people, 46.67%
Pain: 5 people, 33.33%
Drug Ineffective: 4 people, 26.67%
Burning Sensation: 4 people, 26.67%
Wound: 3 people, 20.00%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 20.00%
Infection: 3 people, 20.00%
Cellulitis (infection under the skin): 3 people, 20.00%
Body Temperature Decreased: 3 people, 20.00%

What are the existing conditions these people have? *

Acarodermatitis (skin inflammation caused by mites (acarids)): 5 people, 33.33%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 20.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 20.00%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 13.33%
Bed Bug Infestation: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Permethrin and have Skin exfoliation?

- Check whether Skin exfoliation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Permethrin:

Permethrin (1,547 reports)

Skin exfoliation treatments and more:

Skin exfoliation (79,571 reports)

Browse all side effects of Permethrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin exfoliation:

Skin exfoliation (1,731 drugs)

Browse all the conditions that are associated with Skin exfoliation:

Skin exfoliation (1,994 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on permethrin (the active ingredients of Permethrin) and Permethrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.